SCHEMBL7189644

SCHEMBL7189644

Cc1ccc(O)c(P(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 4/20 0.45
HSD17B10 Q99714 3/20 0.45
ALDH1A1 P00352 2/20 0.45
TRPA1 O75762 1/20 0.45
LMNA P02545 4/20 0.44
MEN1 O00255 3/20 0.44
GAA P10253 3/20 0.44
KMT2A Q03164 3/20 0.44
HPGD P15428 3/20 0.44
TP53 P04637 2/20 0.44
MAPT P10636 2/20 0.44
ALOX12 P18054 1/20 0.44
TDP1 Q9NUW8 3/20 0.43
FTO Q9C0B1 1/20 0.43
ESR1 P03372 2/20 0.42
ESR2 Q92731 2/20 0.42
CSNK2A1 P68400 1/20 0.41
CYP3A4 P08684 1/20 0.41
KCNMA1 Q12791 1/20 0.40
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5596542 0.96 ALOX15 (0.45) ALOX15HSD17B10ALDH1A1TRPA1LMNA
SCHEMBL6438829 0.83 TRPA1 (0.56) ALOX15HSD17B10ALDH1A1TRPA1LMNA
SCHEMBL15723539 0.82 TDP1 (0.46) ALDH1A1LMNAGAAHPGDALOX12
SCHEMBL3679308 0.80 ESR2 (0.56) ALOX15HSD17B10ALDH1A1LMNAMEN1
SCHEMBL12592439 0.80 TDP1 (0.44) ALDH1A1LMNAMEN1GAAKMT2A
SCHEMBL25176323 0.80 ESR2 (0.56) ALOX15HSD17B10ALDH1A1LMNAMEN1
SCHEMBL29543525 0.80 ESR2 (0.56) ALOX15HSD17B10ALDH1A1LMNAMEN1
SCHEMBL9909848 0.79 TDP1 (0.52) ALOX15HSD17B10ALDH1A1LMNAMEN1
SCHEMBL7187736 0.79 TRPA1 (0.39) ALOX15HSD17B10ALDH1A1TRPA1LMNA
SCHEMBL7193988 0.79 TRPA1 (0.39) ALOX15HSD17B10ALDH1A1TRPA1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130005972-A1 Application of Staudinger Ligation in PET Imaging SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-01-03 US disclosed
WO-2011123444-A1 APPLICATION OF STAUDINGER LIGATION IN PET IMAGING SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2011-10-06 WO disclosed
US-6559326-B1 Substituted phosphinophenoxide-metal complexes for the polymerization of olefins BASF AKTIENGESELLSCHAFT (DE) 2003-05-06 US disclosed
EP-1101768-B1 Substituted Phosphanylphenolato[P,O]-metal-complexes for Polymerisation of Olefines BASF AG (DE) 2002-10-02 EP disclosed
EP-1101768-A1 Substituted Phosphanylphenolato[P,O]-metal-complexes for Polymerisation of Olefines BASF AKTIENGESELLSCHAFT (DE) 2001-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005972-A1 Application of Staudinger Ligation in PET Imaging SSTR4, TIE1, STAU1 ALOX15 2545/4885HSD17B10 3696/4885ALDH1A1 1018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.